Sildenafil Tablet
Product Images NDC 51655-172

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 51655-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 172 20 Rev A 04 23)

Label for Sildenafil Tablets, USP 20 mg oral tablets, containing 20 tablets per container. The label includes storage instructions, manufacturer Northwind Pharmaceuticals LLC, and identifies the product as prescription only (Rx Only). The NDC number 51655-172-20 and other product codes are also visible.*

FDA Label Image

Sildenafil-citrate-1 (Sildenafil Tablets 20mg 1)

A line chart depicting the estimated cumulative mortality rate (%) over time (years) for three dosage groups labeled High Dose, Medium Dose, and Low Dose. The chart shows separate stepped lines representing mortality rates increasing over five years, with the High Dose group having the highest mortality rate, followed by Medium Dose, and then Low Dose. A table above the graph indicates the number of patients at risk at different years for each dosage group.*

FDA Label Image

1 (Sildenafil Tablets 20mg 2)

Chemical structure of Sildenafil, showing its distinct molecular arrangement including a pyrazolo[4,3-d]pyrimidinone core and sulfonamide group, consistent with the active ingredient in Sildenafil tablets.*

FDA Label Image

1 (Sildenafil Tablets 20mg 3)

A chart illustrating the fold change and 90% confidence interval (CI) of pharmacokinetic parameters AUC and Cmax for various interacting drugs compared to Sildenafil alone. The chart includes drugs like Atorvastatin, Azithromycin, Bosentan, Cimetidine, and others, with corresponding recommendations on dose adjustment or coadministration notes.*

FDA Label Image

8.1 (Sildenafil Tablets 20mg 4)

A forest plot chart illustrating fold change with 90% confidence intervals for various interacting drugs relative to the interacting drug alone. The chart includes drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, and others, with recommendations for dose adjustments, mostly indicating 'No dose adjustment' except for specific notes on Ritonavir and Bosentan in relation to Sildenafil.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 20mg 5)

A line chart comparing changes from baseline in meters over weeks 4, 8, and 12 among different sildenafil dosages (40 mg TID, 60 mg TID, and 20 mg TID) and a placebo group. The chart includes error bars representing variability at each time point for the four groups over the course of the study.*

FDA Label Image

10.1 (Sildenafil Tablets 20mg 6)

A horizontal bar chart depicting placebo-corrected changes in 6-minute walk distance (meters) for sildenafil 20 mg taken three times daily (TID) compared to placebo. The chart includes subgroups based on baseline walk distance, etiology of pulmonary arterial hypertension (PAH), functional class, gender, age, mean pulmonary artery pressure (PAP), and pulmonary vascular resistance index (PVRI). Each subgroup lists placebo and sildenafil sample sizes alongside horizontal error bars representing variability.*

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 20mg 7)

A line graph comparing the percentage of patients without a clinically worsening event over time (up to 112 days) between Sildenafil and placebo groups. The x-axis represents days from randomization, while the y-axis shows the percentage without event. Sildenafil is represented by a dashed line consistently higher than the solid line for placebo, indicating better outcomes with Sildenafil.*

FDA Label Image

1 (Sildenafil Tablets 20mg 8)

A line chart displaying mean change from baseline in meters over weeks 4, 8, and 12 of study for Sildenafil at 1 mg TID, 5 mg TID, and 20 mg TID doses. The vertical axis shows change from baseline in meters, and error bars represent standard error for each treatment at each visit up to week 12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.